These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Current rabies vaccines and prophylaxis schedules: preventing rabies before and after exposure. Warrell MJ Travel Med Infect Dis; 2012 Jan; 10(1):1-15. PubMed ID: 22342356 [TBL] [Abstract][Full Text] [Related]
5. A 1-week intradermal dose-sparing regimen for rabies post-exposure prophylaxis (RESIST-2): an observational cohort study. Cantaert T; Borand L; Kergoat L; Leng C; Ung S; In S; Peng Y; Phoeun C; Hing C; Taing CN; Saman M; Ong S; Mey C; Choeung R; Ly S; Dussart P; Bourhy H; Tarantola A Lancet Infect Dis; 2019 Dec; 19(12):1355-1362. PubMed ID: 31570311 [TBL] [Abstract][Full Text] [Related]
6. Intradermal post-exposure rabies vaccination with purified Vero cell rabies vaccine: Comparison of a one-week, 4-site regimen versus updated Thai Red Cross regimen in a randomized non-inferiority trial in the Philippines. Quiambao BP; Ambas C; Diego S; Bosch Castells V; Korejwo J; Petit C; Houillon G Vaccine; 2019 Apr; 37(16):2268-2277. PubMed ID: 30890382 [TBL] [Abstract][Full Text] [Related]
7. Intradermal rabies vaccination: the evolution and future of pre- and post-exposure prophylaxis. Warrell MJ Curr Top Microbiol Immunol; 2012; 351():139-57. PubMed ID: 21267707 [TBL] [Abstract][Full Text] [Related]
8. Shortening intradermal rabies post-exposure prophylaxis regimens to 1 week: Results from a phase III clinical trial in children, adolescents and adults. Kerdpanich P; Chanthavanich P; De Los Reyes MR; Lim J; Yu D; Ama MC; Mojares Z; Casula D; Arora AK; Pellegrini M PLoS Negl Trop Dis; 2018 Jun; 12(6):e0006340. PubMed ID: 29874228 [TBL] [Abstract][Full Text] [Related]
9. Introduction of intradermal rabies vaccination - A paradigm shift in improving post-exposure prophylaxis in Asia. Gongal G; Sampath G Vaccine; 2019 Oct; 37 Suppl 1():A94-A98. PubMed ID: 30150166 [TBL] [Abstract][Full Text] [Related]
10. Rabies neutralizing antibody after 2 intradermal doses on days 0 and 21 for pre-exposure prophylaxis. Wongsaroj P; Udomchaisakul P; Tepsumethanon S; Khawplod P; Tantawichien T Vaccine; 2013 Mar; 31(13):1748-51. PubMed ID: 23370149 [TBL] [Abstract][Full Text] [Related]
11. Intradermal rabies post-exposure prophylaxis can be abridged with no measurable impact on clinical outcome in Cambodia, 2003-2014. Tarantola A; Ly S; Chan M; In S; Peng Y; Hing C; Taing CN; Phoen C; Ly S; Cauchemez S; Buchy P; Dussart P; Bourhy H; Mary JY Vaccine; 2019 Oct; 37 Suppl 1():A118-A127. PubMed ID: 30454946 [TBL] [Abstract][Full Text] [Related]
12. Rabies post-exposure prophylaxis vaccination with purified chick embryo cell vaccine (PCECV) and purified Vero cell rabies vaccine (PVRV) in a four-site intradermal schedule (4-0-2-0-1-1): an immunogenic, cost-effective and practical regimen. Ambrozaitis A; Laiskonis A; Balciuniene L; Banzhoff A; Malerczyk C Vaccine; 2006 May; 24(19):4116-21. PubMed ID: 16545510 [TBL] [Abstract][Full Text] [Related]
13. Comparison of safety and immunogenicity of 2 WHO prequalified rabies vaccines administered by one week, 4 site intra dermal regimen (4-4-4-0-0) in animal bite cases. Narayana A; Manoharan A; Narayan MS; Kalappa SM; Biligumba G; Haradanahalli R; Anand AM Hum Vaccin Immunother; 2015; 11(7):1748-53. PubMed ID: 26083005 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of a one week intradermal regimen for rabies post-exposure prophylaxis: results of a randomized, open label, active-controlled trial in healthy adult volunteers in India. Sudarshan MK; Narayana DH; Madhusudana SN; Holla R; Ashwin BY; Gangaboraiah B; Ravish HS Hum Vaccin Immunother; 2012 Aug; 8(8):1077-81. PubMed ID: 22699446 [TBL] [Abstract][Full Text] [Related]
15. Economical multi-site intradermal regimen with purified chick embryo cell vaccine (Rabipur) prevents rabies in people bitten by confirmed rabid animals. Madhusudana SN; Anand NP; Shamsundar R Int J Infect Dis; 2002 Sep; 6(3):210-4. PubMed ID: 12718837 [TBL] [Abstract][Full Text] [Related]
16. Safety and Immunogenicity of purified chick embryo cell rabies vaccine (VaxiRab N) administered intradermally as post exposure prophylaxis. Ravish HS; Vijayashankar V; Madhusudana SN; Sudarshan MK; Narayana DH; Andanaiah G; Ashwin BY; Rachana AR; Shamanna M Hum Vaccin Immunother; 2014; 10(8):2433-7. PubMed ID: 25424951 [TBL] [Abstract][Full Text] [Related]
17. A single center, open label study of intradermal administration of an inactivated purified chick embryo cell culture rabies virus vaccine in adults. Recuenco S; Warnock E; Osinubi MOV; Rupprecht CE Vaccine; 2017 Aug; 35(34):4315-4320. PubMed ID: 28688782 [TBL] [Abstract][Full Text] [Related]
18. Intra-dermal administration of rabies vaccines in developing countries: at an affordable cost. Verma R; Khanna P; Prinja S; Rajput M Hum Vaccin; 2011 Jul; 7(7):792-4. PubMed ID: 21734465 [TBL] [Abstract][Full Text] [Related]
19. Rabies post-exposure prophylaxis: A systematic review on abridged vaccination schedules and the effect of changing administration routes during a single course. Kessels J; Tarantola A; Salahuddin N; Blumberg L; Knopf L Vaccine; 2019 Oct; 37 Suppl 1():A107-A117. PubMed ID: 30737043 [TBL] [Abstract][Full Text] [Related]
20. Serologic Response of 2 Versus 3 Doses and Intradermal Versus Intramuscular Administration of a Licensed Rabies Vaccine for Preexposure Prophylaxis. Endy TP; Keiser PB; Wang D; Jarman RG; Cibula D; Fang H; Ware L; Abbott M; Thomas SJ; Polhemus ME J Infect Dis; 2020 Apr; 221(9):1494-1498. PubMed ID: 31802120 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]